RealBio Technology, Inc.

RealBio Technology, Inc.

RealBio Technology, Inc.

Overview
Date Founded

2009

Headquarters

4717 Campus Drive,Suite 1500,Kalamazoo, MI 49008

Type of Company

Private

Industries

Biotechnology
Holding Companies
Chemicals

Company Description

RealBio Technology, Inc. develops cell and tissue culture technologies. It introduced D4 Culture System-an advanced, disposable cell culture platform capable of developing full three-dimensional cell structures in vitro. The firm's D4 Culture System enables customers to develop cell structures that mimic the natural composition, configuration and function of normal and diseased tissue. The company was founded by Lee Noll in June 2009 and is headquartered in Kalamazoo, MI.

Executives & Employees

President & Chief Executive Officer

Paths to RealBio Technology, Inc.
Potential Connections via
Relationship Science
You
RealBio Technology, Inc.
Recent Transactions
Details Hidden

RealBio Technology, Inc. raised money in a private placement transaction

Details Hidden

RealBio Technology, Inc. raised money in a private placement transaction

Investors
Details Hidden

BRCC is a commercially focused and science driven transitional research center that dedicates their pharmaceutical expertise and resources to the commercialization of promising life sciences discoveries and the growth of Michigan's life sciences business sector

Details Hidden

Ann Arbor Spark Business Accelerator seeks to advance the economic development of innovation-based early-stage and emerging growth companies located in the Ann Arbor, Michigan region. They offer programs, resources and support to businesses at every stage, from start-ups to larger organizations looking for expansion opportunities.The Michigan Pre-Seed Capital Fund Micro Loan Program seeks investments in Michigan-based high-technology start-up companies as they get close to commercial viability by providing access to early-state capital. These funds extend the personal investment of entrepreneurs during the critical time they are preparing for outside investment. The fund targets companies throughout Michigan that are creating new technologies in (1) advanced automotive, manufacturing and materials (2) alternative energy (3) homeland security and defense and (4) life sciences. Loans range from $10,000 to $50,000. Companies must be pre-revenue and have the rights (ownership or license) to innovative technology or be seeking a strong IP position. Loans may not be made to a publicly-held company, but may be utilized to spin technology out of a public company and establish a new private entity. Companies must also have potential for rapid growth and annual sales of over $10 million within 5 years.The Eastern Washtenaw Micro Loan Fund seeks investments in innovative, high-growth start-up companies throughout Michigan's eastern Washtenaw County. The fund focuses on investments in companies as they near commercial viability. The fund looks for companies in the following sectors: (1) advanced automotive, manufacturing, and materials (2) alternative energy (3) homeland security and defense (4) the life sciences (5) information technology (6) Web 2.0 and social networking and (7) business-to-business and business-to-consumer technology services and products.The Ann Arbor Micro Loan Fund seeks to invest in innovative, high-growth start-up companies in the city of Ann Arbor as they near commercial viability. The fund looks for companies in the following sectors: (1) advanced automotive, manufacturing, and materials (2) alternative energy (3) homeland security and defense (4) the life sciences (5) information technology (6) Web 2.0 and social networking and (7) business-to-business and business-to-consumer technology services and products.

Details Hidden

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies to repair and regenerate damaged tissues and organs to normal structure and function. Its product portfolio include MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns comprising a total body surface area of greater than or equal to 30%. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by RealBio Technology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of RealBio Technology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and RealBio Technology, Inc..